drug protocol number

I4V-MCB009

drug sponsor

Eli Lilly

drug study

Baricitinib

drug trial site

Specialized Medical Center (Riyadh), Dr. Sulaiman Al-Habib Medical Group Takhassusi (Riyadh)

drug status

Ongoing

drug phase